Google DeepMind’s AlphaProteo AI is transforming protein design, enabling the creation of proteins that may treat diseases such as cancer and COVID-19 much faster than traditional methods. By targeting specific proteins, this AI model accelerates drug discovery and disease research, significantly outpacing human-designed proteins. AlphaProteo is set to redefine the landscape of medicine and biotechnology.
